Paper Details
- Home
- Paper Details
Assessment of the effects of renal impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).
Author: BeckerCorina, FreyReiner, MückWolfgang, SchmidtAnja, UngerSigrun, WensingGeorg
Original Abstract of the Article :
Renal impairment is a common comborbidity in patients with pulmonary hypertension. The breakdown of riociguat, an oral soluble guanylate cyclase stimulator used to treat pulmonary hypertension, may be affected by smoking because polycyclic aromatic hydrocarbons in tobacco smoke induce expression of ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860531/
データ提供:米国国立医学図書館(NLM)
Riociguat: A Camel's Guide to Navigating Pulmonary Hypertension
Pulmonary hypertension is a serious condition, like a sandstorm swirling through the lungs, making it difficult to breathe. Riociguat, a medication that stimulates the production of a molecule that helps relax blood vessels, is like a refreshing breeze, easing the pressure and improving breathing. This research, like a camel navigating a challenging desert terrain, examines the effects of renal impairment and smoking on the pharmacokinetics of riociguat.
The study, conducted in two non-randomized, non-blinded studies, investigated the pharmacokinetics of riociguat in individuals with varying degrees of renal impairment and in smokers and non-smokers. The researchers found that renal impairment can reduce the clearance of riociguat, leading to higher levels of the drug in the body. They also found that smoking may affect riociguat metabolism, possibly leading to lower levels of the drug. This information, like a camel's ability to adapt to different desert conditions, helps clinicians tailor treatment strategies to individual patient needs.
Riociguat Pharmacokinetics: A Camel's Perspective on Individual Differences
This research highlights the importance of considering individual factors, like renal impairment and smoking, when prescribing riociguat. It's like a camel adapting its pace and water intake based on the terrain and weather conditions. Understanding these factors can help clinicians optimize treatment and achieve the best possible outcomes for their patients.
Pulmonary Hypertension: A Camel's Journey Through the Desert of Breathing
Pulmonary hypertension can be a challenging condition, like navigating a desert with limited water sources. This research provides valuable information for clinicians treating patients with pulmonary hypertension. It's a reminder that every patient is unique and requires individualized treatment strategies, considering their specific needs and circumstances. It's like finding a hidden oasis in the desert - a source of relief and hope for those facing this challenging condition.
Dr.Camel's Conclusion
This research underscores the importance of considering individual factors, like renal function and smoking status, when prescribing riociguat. It's a reminder that just like a camel navigating a desert, we need to be mindful of the unique conditions and challenges faced by each patient.
Date :
- Date Completed 2016-05-10
- Date Revised 2020-09-30
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.